Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 667 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Jade Biosciences, Inc.
Market Cap
$834.39M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
N/A
Market Cap
$841.19M
Operating Margin
-69.75%
TTM Avg
-70.49%
3Y Avg
-9306.05%
5Y Avg
-9306.05%
Market Cap
$843.76M
Operating Margin
-1776.32%
TTM Avg
-888.16%
3Y Avg
-444.08%
5Y Avg
-444.08%
Market Cap
$823.84M
Operating Margin
-7.86%
TTM Avg
-9.22%
3Y Avg
-47.88%
5Y Avg
-486.53%
Market Cap
$844.84M
Operating Margin
-348.46%
TTM Avg
-328.22%
3Y Avg
-265.67%
5Y Avg
-226.03%
Market Cap
$866.04M
Operating Margin
-43.83%
TTM Avg
-75.55%
3Y Avg
-37.77%
5Y Avg
-25.18%
Market Cap
$798.38M
Operating Margin
9.86%
TTM Avg
12.61%
3Y Avg
-6.26%
5Y Avg
-239.99%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jade Biosciences, Inc. (JBIO) | $834.39M | 0.00% | 0.00% | 0.00% | N/A |
| Beta Bionics, Inc. (BBNX)vs › | $841.19M | -69.75% | -70.49% | -9306.05% | -9306.05% |
| Alumis Inc. (ALMS)vs › | $843.76M | -1776.32% | -888.16% | -444.08% | -444.08% |
| Ardelyx, Inc. (ARDX)vs › | $823.84M | -7.86% | -9.22% | -47.88% | -486.53% |
| Pacific Biosciences of California, Inc. (PACB)vs › | $844.84M | -348.46% | -328.22% | -265.67% | -226.03% |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $866.04M | -43.83% | -75.55% | -37.77% | -25.18% |
| InMode Ltd. (INMD)vs › | $804.16M | 18.47% | 25.77% | 33.72% | 36.17% |
| Apnimed, Inc. (APMD)vs › | $802.04M | N/A | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $798.38M | 9.86% | 12.61% | -6.26% | -239.99% |
| AdaptHealth Corp. (AHCO)vs › | $789.92M | -0.31% | 6.92% | 0.39% | 2.91% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
